SEC Form 4/A · accession 0001526335-15-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Brian J. Underdown
Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 9:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.80 | Jun 17, 2015 | A | 5,500 | A | — | Jun 16, 2025 | Common Stock | 5,500 | 5,500 | D |
Explanation of responses
- F1This option was granted on June 17, 2015 and vests in equal amounts quarterly over the 12 month period beginning June 17, 2015.